Phase
Condition
Diabetic Kidney Disease
Diabetes Prevention
Diabetes Mellitus, Type 2
Treatment
Dextran 40
Iohexol Inj 300 MG/ML
Aminohippurate Sodium Inj 20%
Clinical Study ID
Ages 8-14 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
HbA1c ≥6.0% for untreated high-risk group
BMI ≥ 85th %ile for high-risk group
Normal HbA1c ≤5.6% for control group
Type 1 diabetes (T1D) Antibody negative
Exclusion
Exclusion Criteria:
History of Chronic kidney disease (CKD) or acute kidney injury (AKI)
Metabolic disorder prohibiting safe fasting
Iodine or penicillin allergy
Pregnancy
Thrombophilia
MRI contraindications
Hormone therapy
Study Design
Study Description
Connect with a study center
Children's Hospital Colorado
Aurora, Colorado 80045
United StatesActive - Recruiting
Seattle Children's Hospital
Seattle, Washington 98102
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.